Drreddys Laboratories reported INR142.59B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
ANI Pharmaceuticals USD 236.83M 35.02M Jun/2025
Aurora Cannabis CAD 156.88M 7.07M Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Canopy Growth CAD 98.67M 1.65M Jun/2025
Cipla INR 54.84B 291.6M Mar/2025
Corcept Therapeutics USD 144.66M 1.6M Jun/2025
Drreddys Laboratories INR 142.59B 10.64B Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
Hikma Pharmaceutical USD 1.98B 598M Dec/2024
Lonza CHF 3.58B 970M Dec/2024
Novartis USD 31.71B 95M Jun/2025
Pacira USD 313.16M 1.57M Jun/2025
Prestige Brands USD 109.67M 3.04M Jun/2025
Richter Gedeon HUF 175.24B 34.29B Dec/2024
Sun Pharmaceuticals INR 181.94B 9.39B Mar/2025
Supernus Pharmaceuticals USD 286.36M 4.59M Jun/2025
Teva Pharmaceutical Industries USD 11.86B 704M Jun/2025